Remote Preconditioning Over Time To Empower Cerebral Tissue (REM-PROTECT)
Pilot, Randomized, Controlled, Staggered Start, Feasibility Trial of Ischemic Preconditioning, a Promising Novel Treatment for Stroke Prevention
Sponsor: American Heart Association
Terminated
COVID 19 restrictions
Other terminated trials from American Heart Association
A NA clinical study on Cerebral Small Vessel Disease and Cognitive Decline, this trial is terminated or withdrawn. The trial is conducted by American Heart Association and has accumulated 11 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2024 [monthly]
Terminated NA
-
Apr 2021 — Dec 2021 [monthly]
Terminated NA
-
Jan 2021 — Apr 2021 [monthly]
Terminated NA
▶ Show 6 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Terminated NA
Status: Suspended → Terminated
-
May 2020 — Dec 2020 [monthly]
Suspended NA
Status: Recruiting → Suspended
-
Apr 2019 — May 2020 [monthly]
Recruiting NA
-
Jun 2018 — Apr 2019 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Nov 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- American Heart Association
- University of California, Los Angeles
For direct contact, visit the study record on ClinicalTrials.gov .